Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.identifier.citationUchida, H., Suzuki, T., Takeuchi, H., & Mamo, D. C. (2010). Analysis of antipsychotic dose reduction. American Journal of Psychiatry, 167(8), 994-994.en_GB
dc.description.abstractIn the June 2010 issue of the Journal, Chuan-Yue Wang, M.D., Ph.D., et al. (1) conducted an open-label randomized controlled trial to examine the effects of reducing the risperidone dose in schizophrenia patients who had completed an acute phase treatment. The authors concluded that maintenance treatment at the initial dose for at least 1 year was safer and more effective in relapse prevention than the reduced dose strategy.en_GB
dc.publisherAmerican Psychiatric Publishing, Inc.en_GB
dc.subjectAntipsychotic drugsen_GB
dc.subjectSchizophrenia -- Diagnosisen_GB
dc.titleAnalysis of antipsychotic dose reductionen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holderen_GB
dc.publication.titleAmerican Journal of Psychiatryen_GB
dc.contributor.creatorUchida, Hiroyuki-
dc.contributor.creatorSuzuki, Takefumi-
dc.contributor.creatorTakeuchi, Hiroyoshi-
dc.contributor.creatorMamo, David-
Appears in Collections:Scholarly Works - FacM&SPsy

Files in This Item:
File Description SizeFormat 
Analysis_of_Antipsychotic_Dose_Reduction.pdf61.87 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.